South Africa's SAHPRA: Communication to Industry on Quality Variations
EMA Guideline: Quality and Equivalence of Locally Applied, Locally Acting Cutaneous Products
USFDA Guidance: "Understanding FDA's QMSR Final Rule: What You Need to Know for the Transition Period"
USFDA MD Guidance: Cybersecurity-Quality System Considerations & Content of Premarket Submissions
Ireland's HPRA: Guidance on Reporting & Investigation of Quality Defects
South Africa: Information Guideline and Quality and Bioequivalence guidelines Aligning with EMA/ICH
USFDA POLICY AND PROCEDURES: Quality Assessment for Products in Expedited Programs
Colombia's Invima and USP: Memorandum to Strenghthen the Quality of Medicine
USFDA Guidance on “Pharm. Quality/CMC Data Exchange" and Drug Products containing Nanoparticles
Guide to Reporting and Initial Investigation of Quality Defects-Ireland HPRA